Athersys Price (ATHX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

11,945,000

(33.1513)%

Athersys Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.0045-1.99
  • Market Cap 0.00
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Biotechnology

  • ceo: Ms. Z. Kasey Rosado
  • IPO Date: June, 12, 2007
  • Country: US
  • Currency: USD
  • Headquaters: Cleveland, OH
  • Employees: 24

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation